Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Name: Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
License: Public Domain

University of California, Davis

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally recurrent head and neck squamous cell carcinoma, metastatic head and neck squamous cell carcinoma, refractory head and neck squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158108
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.